Search

What is another word for Antineoplastic Agent Resistance?

Pronunciation: [ˌantɪnˌiːə͡ʊplˈastɪk ˈe͡ɪd͡ʒənt ɹɪsˈɪstəns] (IPA)

Antineoplastic Agent Resistance, also known as drug resistance, is a significant challenge faced in cancer treatment. This phenomenon occurs when cancer cells become resistant to the effects of antineoplastic agents, rendering them ineffective. Scientists and researchers constantly strive to find innovative solutions to overcome this resistance. Synonyms for Antineoplastic Agent Resistance include drug tolerance, medication insensitivity, therapeutic resistance, or treatment unresponsiveness. Understanding these terms helps medical professionals communicate effectively about the complexities of drug resistance, fostering collaboration and improving patient care. By exploring new approaches and developing targeted therapies, experts hope to combat drug resistance and enhance the efficacy of antineoplastic agents in the battle against cancer.
Opposite words
Antonyms
Search

What are the opposite words for Antineoplastic Agent Resistance?

The opposite of antineoplastic agent resistance is antineoplastic agent sensitivity. Antineoplastic agents are chemicals used in chemotherapy to kill cancer cells or slow tumor growth. When a patient is sensitive to antineoplastic agents, it means the cancer cells respond well to the treatment and can be effectively eliminated. This can lead to complete remission or long-term survival. However, when cancer cells become resistant to the drugs, the treatment becomes ineffective, and the cancer can continue to grow and spread. Antineoplastic agent sensitivity is essential for successful cancer treatment, and research is ongoing to overcome drug resistance and improve patient outcomes.

What are the antonyms for Antineoplastic agent resistance?

Word of the Day

Ocular Disparity
Ocular disparity refers to the difference in perspective between the eyes, which allows for depth perception. The antonym of ocular disparity would be "ocular homogeneity," which r...